Compare FEIM & CYRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | FEIM | CYRX |
|---|---|---|
| Founded | 1961 | 1999 |
| Country | United States | United States |
| Employees | N/A | 1100 |
| Industry | Electrical Products | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 439.6M | 419.3M |
| IPO Year | 1994 | 2008 |
| Metric | FEIM | CYRX |
|---|---|---|
| Price | $57.52 | $13.07 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 2 | 8 |
| Target Price | ★ $51.50 | $13.31 |
| AVG Volume (30 Days) | 134.4K | ★ 578.9K |
| Earning Date | 03-11-2026 | 05-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 316.95 | 156.22 |
| EPS | ★ 0.41 | N/A |
| Revenue | $69,811,000.00 | ★ $176,177,000.00 |
| Revenue This Year | N/A | $11.06 |
| Revenue Next Year | $21.73 | $8.45 |
| P/E Ratio | $146.74 | ★ N/A |
| Revenue Growth | ★ 26.30 | N/A |
| 52 Week Low | $17.56 | $5.31 |
| 52 Week High | $64.99 | $13.79 |
| Indicator | FEIM | CYRX |
|---|---|---|
| Relative Strength Index (RSI) | 52.59 | 71.05 |
| Support Level | $42.53 | $7.98 |
| Resistance Level | $59.75 | N/A |
| Average True Range (ATR) | 4.20 | 0.69 |
| MACD | 0.35 | 0.14 |
| Stochastic Oscillator | 60.10 | 82.91 |
Frequency Electronics Inc is engaged in the design, development, and manufacture of high-precision timing, and frequency control products for space, air, sea, and terrestrial applications. The company has FEI-NY and FEI-Zyfer reportable segments. It derives the majority of its revenues from the FEI-NY segment. FEI-NY segment operations consist principally of precision time and frequency control products used in three principal markets namely communication satellites (both commercial and U.S. Government-funded); terrestrial cellular telephone or other ground-based telecommunication stations; and other components and systems for the U.S. military.
CryoPort Inc is a provider of integrated, temperature-controlled supply chain solutions for the life sciences industry, with a focus on supporting the cell and gene therapy market. The company provides services such as temperature-controlled logistics, biostorage, bioservices, cryopreservation solutions, and cryogenic systems manufacturing. It operates through two reportable segments: Life Sciences Services and Life Sciences Products. It generates the majority of its revenue from the Life Sciences Services segment.